US withdrawals of funding and pharmaceutical tariffs have left European drug development on a cliff edge, delegates at the European Health Forum in Gastein, Austria, have warned.
The concerns come amid admissions from European World Health Organization officials that they believe that the organisation’s progress is “increasingly coming under scrutiny and under threat.”
In May the Trump administration stopped the US National Institutes of Health (NIH) approving new research grants to …
